Telix Pharmaceuticals Market Cap

Telix Pharmaceuticals has a market cap or net worth of $5.30 billion as of July 7, 2025. Its market cap has increased by 20.59% in one year.

Market Cap

5.30B

Enterprise Value

5.22B

Revenue

484.69M

Ranking

n/a

PE Ratio

171.61

Stock Price

$15.41

Market Cap Chart

Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 115.28M to 5.30B, an increase of 4,498.81%. That is a compound annual growth rate of 64.98%.

Market Cap History

Date	Market Cap	% Change
Jul 7, 2025	5.33B	4.56%
Dec 31, 2024	5.10B	129.18%
Dec 29, 2023	2.22B	42.30%
Dec 30, 2022	1.56B	-2.70%
Dec 31, 2021	1.61B	96.45%
Dec 31, 2020	817.72M	196.48%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.62B
Veradigm	823.67M
Nika Pharmaceuticals	708.22M
Elite Pharmaceuticals	639.84M
Tian'an Technology Group	628.15M
Glass House Brands	536.01M
American Oncology Network	433.75M
Northwest Biotherapeutics	362.46M

Market Cap Rankings